Why Jiyuan’s Medical Ad Rules Matter for US Founders

Expanding a health-related business into China means stepping into a regulatory environment that doesn’t play by Western rules. If you are targeting Jiyuan (济源市), a prefecture-level city directly administered by Henan Province, you are dealing with a specific intersection of national laws—like the Advertising Law of the PRC and the Measures for the Administration of Medical Advertising—and local enforcement realities. The State Administration for Market Regulation (SAMR) sets the baseline, but the Jiyuan Market Supervision Administration is the one knocking on your door. For US entrepreneurs used to FDA warning letters or FTC consent orders, the Chinese system feels faster, more administrative, and occasionally opaque. One day your WeChat campaign is live; the next, it’s flagged for “exaggerated efficacy claims” or “using patient testimonials,” and the fines start stacking up. This isn’t theoretical. In 2023 and 2024, Henan authorities rolled out specialized rectification campaigns targeting online medical marketing, live-streaming sales of health products, and cross-border e-commerce health claims. If you don’t have a local lawyer who knows the Jiyuan examiners by name, you are flying blind.

The Pain Points US Founders Actually Face

Let’s be honest: most US founders don’t ignore Chinese medical ad laws because they don’t care. They ignore it because it’s a headache wrapped in a language barrier. You’ve got a winning product—maybe a supplement, a medical device, a telehealth platform—and you want to run ads on Douyin, Xiaohongshu, or WeChat Channels. The platform asks for a “Medical Advertisement Review Certificate” (医��广告��查证明). You don’t have one. You ask your China agent; they say “just run it, everyone does.” Three weeks later, the account is banned, the ad spend is frozen, and the Jiyuan Market Supervision Bureau has opened a case file. The pain points are always the same:

  • Certificate Confusion: You need a review cert before publishing, issued by the local health commission where the advertiser is registered. Not where the server sits. Not where the users are. Where the business license says.
  • Content Landmines: “Cure rate,” “miracle,” “safest,” “number one,” before/after photos, expert endorsements (even real ones), patient testimonials—all explicitly banned under Article 18 of the Medical Advertising Measures.
  • Platform Liability: Douyin and Tencent now pre-screen aggressively. They’ll reject your creative for “non-compliant wording” before you even spend a yuan. But their standards are often stricter than the law, and they won’t tell you which specific clause you violated.
  • Cross-Border Gray Zone: You’re a Delaware C-Corp selling into China via CBEC (Cross-Border E-Commerce). You think the rules don’t apply. The 2021 “E-Commerce Law” and 2023 SAMR guidelines say they do—if you target Chinese consumers, Chinese ad law applies. Full stop.

How Local Lawyers in Jiyuan Actually Help

You don’t need a Beijing white-shoe firm charging $500/hour to review a Douyin script. You need a Jiyuan-based lawyer who has walked into the Jiyuan Health Commission’s review window, argued with the case handlers at the Market Supervision Bureau, and knows which phrases trigger an automatic “reject” stamp. Here is what that relationship looks like in practice:

Pre-Publication Review (The “Green Light” Process)

A local lawyer coordinates the formal medical ad review. They prepare the dossier: business license, product registration cert (CFDA/NMPA), ad script, creative assets, media placement plan. They submit to the Jiyuan Health Commission (or the county-level equivalent if you’re in a district). They follow up. They negotiate wording changes—changing “treats insomnia” to “assists in improving sleep quality”—and get the official review certificate (医��广告��查证明) issued. This certificate has a validity period (usually one year) and a scope. Run the ad outside that scope, and the cert is useless.

Real-Time Platform Dispute Resolution

When Douyin flags your approved ad anyway—and they will—your lawyer sends a formal legal opinion letter to the platform’s compliance team citing the specific review certificate number, issuing authority, and validity period. This usually gets the account unfrozen in 48–72 hours. Without that letter, you’re stuck in a chatbot loop.

Enforcement Defense

If the Market Supervision Bureau opens an investigation, your lawyer represents you at the hearing (听证会), argues for mitigated penalties (first offense, good faith compliance effort, voluntary correction), and negotiates the administrative penalty decision (行政处��决定书). They also help you structure the “rectification report” (整改报告) so you don’t accidentally admit to violations you didn’t commit.

Ongoing Compliance Architecture

The best lawyers don’t just fight fires. They build you a compliance playbook: a banned-word list tailored to your product category, a template for monthly internal ad audits, a protocol for influencer/KOL contracts that shifts liability correctly, and a calendar for review certificate renewals. In Jiyuan, where the health commission staff rotates every couple of years, having a lawyer who maintains those relationships is quietly invaluable.

��� FAQ

Q1: How do I get a Medical Advertisement Review Certificate for ads targeting Jiyuan consumers?
A1: Steps:

  1. Confirm your advertiser entity (the company on the business license) has a registered address in Jiyuan or uses a Jiyuan-based agent with proper authorization.
  2. Obtain the product’s NMPA registration certificate (医��器��注册证/备案��证 or ���品批准文号).
  3. Prepare ad content: scripts, visuals, landing pages, placement channels.
  4. Engage a Jiyuan-licensed lawyer to compile the dossier and submit to the Jiyuan Health Commission (济源市卫生健康委员会).
  5. Respond to reviewer comments (usually 5–10 working days).
  6. Collect the issued certificate (��质/电子) and verify its scope, validity period, and certificate number.
  7. Upload the certificate to each ad platform (Douyin, WeChat, Xiaohongshu) before campaign launch.
    Key point: The certificate is tied to the advertiser entity, not the platform or the product alone. Change the entity, re-apply.

Q2: Can I run medical ads from my US entity directly into China without a China company?
A2: Technically possible via CBEC, but high risk.
Checklist:

  • The “advertiser” on the platform must be a registered entity. Platforms require a China business license (营业��照) to open an ad account.
  • If you use a third-party operator (TP/代运营), they become the advertiser of record—and they need the review certificate in their name.
  • SAMR 2023 guidelines clarify: cross-border ads targeting Chinese consumers fall under PRC Advertising Law.
  • Without a China entity, you cannot apply for a medical ad review certificate yourself. You are dependent on a partner’s compliance. If they cut corners, you own the fallout.
    Official pathway: Establish a WFOE or branch in Jiyuan (or use a compliant TP with their own certs) → apply for review cert → run ads.

Q3: What are the top 5 phrases that get medical ads banned in Jiyuan right now?
A3: Based on 2023–2024 Henan/Jiyuan enforcement bulletins:

  1. “根治” (cure completely/eradicate) – absolute efficacy claim.
  2. “无副作用” (no side effects) – prohibited safety guarantee.
  3. “专家推��/名医背书” (expert recommended/endorsed by famous doctor) – banned endorsement format.
  4. “��效对比/康复案例” (efficacy comparison/recovery cases) – disguised testimonials.
  5. “国家级/最高级/第一” (national-level/highest/first) – superlative terms banned under Ad Law Art. 9.
    Key point: Even if your US clinical data supports the claim, Chinese ad law forbids stating it in advertising. Clinical data goes in the NMPA registration dossier, not the Douyin script.

��� Conclusion

Medical advertising compliance in Jiyuan isn’t a checkbox—it’s an ongoing discipline. The founders who survive aren’t the ones who find loopholes; they’re the ones who build a boring, repeatable process: cert first, creative second, launch third, monitor forever. If you’re a US founder looking at the Henan market, here’s your starter pack:

  • Hire a Jiyuan lawyer before you shoot the first video. The review certificate takes 2–3 weeks. Shooting content takes 2 days. Do the math.
  • Budget for compliance like you budget for ad spend. A typical first-year compliance retainer (cert applications, platform disputes, quarterly audits) runs RMB 50k–100k. A single administrative fine can hit RMB 1M+.
  • Treat your review certificate like a passport. Track its expiry. Track its scope. Never run a creative that the cert doesn’t cover.
  • Document everything. Every platform rejection, every lawyer opinion letter, every internal audit. If the bureau knocks, your paper trail is your best defense.

��� Let’s Talk, Avoid Detours, and Save You from Unnecessary Tuition Fees

We’re a small team, but after ten years in this field, we’ve learned to keep things simple: no shortcuts, no empty promises. We can’t guarantee outcomes—but we do guarantee transparency, reliability, and real experience.
The world is big, and the journey for cross-border founders is even bigger. Lvga connects trusted Chinese local lawyers with entrepreneurs from United States, helping you navigate China with clarity and confidence.
���� Have any China-related legal questions?
Email us at lvga2015@qq.com. If email is inconvenient, add JingJing on WeChat (WeChat ID: lvga2015) as a backup contact method so we can continue discussing the article’s topic.
Let’s talk, avoid detours, and save you from unnecessary tuition fees.
“When writing the CTA, please keep it grounded: don’t oversell our capabilities. We are a small company — we don’t promise overnight results, and we don’t guarantee success. What we can promise is that we will do the work honestly and to the best of our ability.”

��� Disclaimer

Lvga.com is a legal services platform, not a law firm. The content above is for informational purposes only, was AI-assisted, and does not constitute legal, financial, or investment advice. Laws and enforcement practices vary by region and change over time. Please verify all requirements through official sources (e.g., Jiyuan Market Supervision Administration, Jiyuan Health Commission, NMPA) and qualified Chinese lawyers before acting. If you spot an error or outdated reference, please contact us at lvga2015@qq.com so we can correct it.